MedTrace Logo

Time-restricted Eating and High Intensity Interval Training Among Women

NCT04019860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2021-09-20

No results posted yet for this study

Summary

This project will determine the independent and combined effects of high intensity interval training and time-restricted eating on blood sugar regulation among women in reproductive-age who have overweight or obesity. The intervention period will be seven weeks. Before and after the intervention, blood sugar regulation, body composition and physical fitness will be measured and compared between groups who are doing either high intensity interval training, time-restricted eating, both high intensity interval training and time-restricted eating, or who are in a control group. Physical activity, sleep quality, continuous glucose monitoring, adherence to the interventions and hunger/satiety will also be measured.

Conditions

  • Obesity; Endocrine

Interventions

BEHAVIORAL

High Intensity Interval Training

Three weekly, supervised exercise sessions with high intensity. Each session will last for 30-45 minutes. Intervention period will be seven weeks.

BEHAVIORAL

Time-Restricted Eating

Restricted daily window of caloric intake to maximum 10 hours. Intervention period will be seven weeks.

Sponsors & Collaborators

  • Australian Catholic University

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Øystein T Risa, PhD · Norwegian University of Science and Technology

  • Trine T Moholdt, PhD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-12
Primary Completion
2021-03-16
Completion
2021-03-16

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019860 on ClinicalTrials.gov